The potential interplay between ferroptosis-related genes and key signaling pathways like NF-κB, STAT3, and p53 suggests that the ferroptosis transcriptional program could be manipulated to enhance medulloblastoma treatment responses. The gene discussed is NFKB1; the disease is medulloblastoma.